Registration Questions

Call: 202-684-2034
Email: eventregistration@bisnow.com

Request Speaker Information

Speaker Topics

Tell us a Little More

Event Host

Princeton West Innovation

Princeton West Innovation

Neighboring Princeton, New Jersey, this pharmaceutical manufacturing R&D campus is in the heart of the U.S. Northeast Corridor, with strategic access to local and global biotech, pharmaceutical, financial, media markets and regulatory centers.

Step into an environment engineered for peak performance. Built with a $500M+ legacy investment from former owner, Bristol-Myers Squibb, this campus offers an unmatched platform for innovation, from existing BSL-2+ R&D facilities, clinical manufacturing and a global data center to +600,000 SF approved development rights. This entire ecosystem is powered by exceptionally robust infrastructure, including a Central Utility Complex (CUC) for reliable site-wide steam and chilled water, a 30MW dual-feed substation (expandable to 70MW), on-site co-generation systems, and decentralized emergency generators to ensure uninterrupted operations.

Beyond the lab and office, attract and retain elite talent with state-of-the-art amenities focused on your team's well-being which include modern conference facilities, a fully equipped fitness center and serene nature trails, creating a workplace where people and progress thrive.

Speakers and Panels

Lance Bergstein

Lance Bergstein

CEO

Lincoln Equities Group

Ed Jaram

Ed Jaram

Senior Director, Head of New York

King Street Properties

Matthew Flath

Matthew Flath

VP, Asset Management

Onyx Equities

Michael Johnson

Michael Johnson

President

New Jersey Innovation Institute

Benjamin Dibling

Benjamin Dibling

Managing Director

Penn Center for Innovation

David Schwarz

David Schwarz

Founding Partner

HUSH

Ed Jaram

Senior Director, Head of New York

King Street Properties

Ed Jaram joined King Street at the start of 2019 to manage project execution in New York and the surrounding markets, and has nearly 20 years’ experience in construction and real estate, both in the US and the UK. Before joining King Street, he ran the in-house construction company for a Manhattan-based developer performing both ground-up and renovation projects, delivering over 1,000,000 sq ft of construction in a three-year period. Before that, he worked for 10 years for Gardiner & Theobald – one of the largest independently-held construction consultancies in the world – and delivered projects with a total value of over $1bn in London, Los Angeles and New York, for clients including the WPP Advertising group, BioMed Realty, and The Dorchester Collection hotel company.

Matthew Flath

VP, Asset Management

Onyx Equities

Matthew joined Onyx Equities in 2016. He oversees implementation and execution of asset level business plans for the retail and industrial segments of the portfolio.

Prior to joining Onyx, Matthew served as Vice President at The Goldstein Group for 8 years, where he facilitated over $78 million in lease transactions, and represented over one million square feet of commercial space throughout the metro-New York market.

Matthew graduated from the University of Richmond with a Bachelor of Arts in Economics and Political Science. In addition, he is a member of the International Council of Shopping Centers and IOREBA.

Michael Johnson

President

New Jersey Innovation Institute

Dr. Johnson is a passionate, hard-working, and disruptive leader that has focused his efforts solely on solving the big problems that our world faces by leading the development, translation and commercialization of paradigm-shifting technologies. Dr. Johnson is currently the President of the New Jersey Innovation Institute (NJII) at the New Jersey Institute of Technology (NJIT) where he oversees a team that is focused on accelerating the development of innovative technologies through leveraging the vast resources of NJIT. While a scientist by training, Dr. Johnson is a skilled commercial leader and has built and overseen every aspect of a company from technology licensing to GAAP and IFRS accounting. Dr. Johnson has been named to the Forbes 30 Under 30 List as well as the NJBIZ Power 50 in Healthcare List and has received two patents in addition to multiple publications and federal/state grants.

Benjamin Dibling

Managing Director

Penn Center for Innovation

Ben Dibling is Managing Director of the Penn Center for Innovation (PCI) at the University of Pennsylvania. Ben leads the PCI team in advancing discoveries and ideas resulting from Penn’s research towards new products, services, and/or businesses to provide benefits back to Penn, its inventors, and society. The PCI team actively facilitates a broad range of technology development connections between Penn and the commercial sector, including technology licenses, R&D alliances, sponsored research, and the formation of new ventures.

Prior to joining PCI and Penn in 2016, Ben was Senior Associate Director of Licensing at UCLA. Ben started his career in technology transfer in 2004 at UChicagoTech, the office of technology and intellectual property at the University of Chicago, and was Program Manager in Oncology at the time he moved to UCLA in 2011.

Ben holds a PhD in Clinical Medicine from the University of Leeds and a B.Med.Sc. in Molecular and Cellular Biology from the University of Birmingham. He is licensed to practice before the United States Patent and Trademark Office and is a Certified Licensing Professional (CLP). Ben is a member of AUTM, LES and prior chair of the Board of Governors for CLP.

David Schwarz

Founding Partner

HUSH

David Schwarz is an award-winning creative executive and founding partner of HUSH. HUSH specializes in designing places, spaces, and experiences that merge behavioral psychology, neuroaesthetics, digital technology, and data to achieve business objectives. Under David’s leadership, HUSH has delivered transformative projects for clients such as Barclays, Chobani, Goldman Sachs, Meta, Samsung, Uber, United Therapeutics, Visa, and beyond, in cities ranging from New York to Riyadh. His thought leadership is widely recognized, with features in publications like Forbes and Fast Company and presentations at premier events including SXSW and Cannes Lions. Beyond his professional endeavors, David is committed to nurturing the next generation of creative leaders. He serves as a mentor at NEW INC., the New Museum’s incubator for art, technology, and design, supporting innovative creative startups poised to change the world.

Why You Should Attend This 2026 Tri-State Life Science Conference

What You'll Learn:

  • As the top U.S. biomanufacturing hub, how are NJ's universities translating research into startup formation and ecosystem growth?

  • With 72% of the national lab pipeline now build to suit, how are developers adapting to a more selective tenant environment?

  • How are spec suites and turnkey lab configurations changing the leasing conversation?

  • With VC funding at its strongest since 2022, how is that renewed capital shaping tenant demand and leasing decisions?

  • How are New York City's academic institutions creating new pathways for emerging life sciences companies to access capital and talent?

  • With nearly 19,000 R&D professionals, how is Philadelphia's cell and gene therapy cluster reshaping the region's competitive landscape?

How you'll do more business:

Enhance your business by understanding how New Jersey, New York and Philadelphia's life sciences developments are positioning themselves amidst the competitive East Coast market. Hear from the top developers and designers on finding the right development locations, identifying when to build on spec and enticing the top tenants. 

Who attends:

Investors, owners, developers, lenders, brokers, architects, contractors, engineers, biotech companies, tenants and more. 

Why should you attend:

Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network, and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us.

For questions, recommendations, comments, or press inquiries please email our Senior Event Producer, Joshua Piquion at joshua.piquion@bisnow.com. For disability related questions, please email, Mackenzie.kunkle@bisnow.com

Agenda

Time Activity
8:30 AM
9:30 AM
Coffee, Breakfast & Networking
9:30 AM
10:15 AM
Universities At The Core: The Intersection of Academia, Research, Incubation & Startups

1.) Gain insight into how academic medical centers and institutions are creating new entry points for early-stage life sciences companies.
2.) Hear how Innovation Centers are connecting founders, investors, and academic institutions to foster research and development across AI, life sciences, and advanced manufacturing.

10:15 AM
11:00 AM
Fueling Discovery: Building Labs & Innovation Hubs of the Future

1.) Explore how transformative projects are redefining the region's lab and innovation infrastructure and attracting new life sciences occupiers.
2.) Understand how the shift toward build-to-suit development is changing how developers approach project feasibility, design, and tenant relationships.

11:00 AM
11:45 AM
How to Implement Flexibility Into Lab Spaces to Drive Leasing Activity

1.) Understand how shrinking lease sizes are changing how landlords design, market, and price lab space.
2.) Explore how spec suites are accelerating leasing decisions.

11:45 AM
12:00 PM
Post Event Networking

Tickets

Super Early Bird

$120.00 /ticket

Save the most registering now!

Sponsors